NCT02176850View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

CompletedOBSERVATIONAL
Enrollment

19,870

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

May 31, 2000

Conditions
Hypertension
Interventions
DRUG

Micardis®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY